Non-Antibody Products — page 4 of 4
Non-Antibody Products
Page 4 of 4
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| DSDP | at 50 µM; inhibits yellow fever, dengue, and Zika viru… | 5 mg | 30156-5 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Suramin (sodium salt) | negatively charged at physiological pH therefore exhibiting polypharmacol… | 100 mg | 11126-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Suramin (sodium salt) | negatively charged at physiological pH therefore exhibiting polypharmacol… | 250 mg | 11126-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NGI 1 | 549 NSCLC cells at 10 µM; inhibits dengue and Zika viru… | 10 mg | 31519-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NGI 1 | 549 NSCLC cells at 10 µM; inhibits dengue and Zika viru… | 25 mg | 31519-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NGI 1 | 549 NSCLC cells at 10 µM; inhibits dengue and Zika viru… | 5 mg | 31519-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NGI 1 | 549 NSCLC cells at 10 µM; inhibits dengue and Zika viru… | 50 mg | 31519-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2?-C-β-Methylguanosine | = 5.2 and 3.2 µM in ELISA and luciferase assays, respectively); inh… | 10 mg | 36548-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2?-C-β-Methylguanosine | = 5.2 and 3.2 µM in ELISA and luciferase assays, respectively); inh… | 25 mg | 36548-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2?-C-β-Methylguanosine | = 5.2 and 3.2 µM in ELISA and luciferase assays, respectively); inh… | 5 mg | 36548-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2?-C-β-Methylguanosine | = 5.2 and 3.2 µM in ELISA and luciferase assays, respectively); inh… | 50 mg | 36548-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mebhydroline (1,5-naphthalenedisulfonate) | -induced transactivation of FXR in HEK293T cells expressing the human rece… | 1 g | 40281-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mebhydroline (1,5-naphthalenedisulfonate) | -induced transactivation of FXR in HEK293T cells expressing the human rece… | 10 g | 40281-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mebhydroline (1,5-naphthalenedisulfonate) | -induced transactivation of FXR in HEK293T cells expressing the human rece… | 25 g | 40281-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mebhydroline (1,5-naphthalenedisulfonate) | -induced transactivation of FXR in HEK293T cells expressing the human rece… | 5 g | 40281-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PKI (14-22) amide (myristoylated) (trifluoroacetate salt) | replication of several strains of Zika virus, including… | 1 mg | 34431-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PKI (14-22) amide (myristoylated) (trifluoroacetate salt) | replication of several strains of Zika virus, including… | 5 mg | 34431-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PKI (14-22) amide (myristoylated) (trifluoroacetate salt) | replication of several strains of Zika virus, including… | 500 µg | 34431-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ML-SA1 | ML-SA1, as a selective TRPML agonist, inhibits Dengue virus 2 (DE… | 100 mg, 250 mg, 1 g | orb1089604 |
 BIORBYT LTD. |
More Info |
| Cephalotaxine | ;M; reduces viral infectivity in Zika virus-infected Ver… | 100 mg | 36521-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cephalotaxine | ;M; reduces viral infectivity in Zika virus-infected Ver… | 250 mg | 36521-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cephalotaxine | ;M; reduces viral infectivity in Zika virus-infected Ver… | 50 mg | 36521-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Palmatine (chloride) | .84 µM, respectively); reduces Zika virus infectio… | 1 g | 30318-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Palmatine (chloride) | .84 µM, respectively); reduces Zika virus infectio… | 5 g | 30318-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Palmatine (chloride) | .84 µM, respectively); reduces Zika virus infectio… | 500 mg | 30318-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Derenofylline | nephrectomized rats at 10 mg / kg per day; reduces relative plaque counts… | 1 mg | 27666-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Derenofylline | nephrectomized rats at 10 mg / kg per day; reduces relative plaque counts… | 10 mg | 27666-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Derenofylline | nephrectomized rats at 10 mg / kg per day; reduces relative plaque counts… | 25 mg | 27666-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Derenofylline | nephrectomized rats at 10 mg / kg per day; reduces relative plaque counts… | 5 mg | 27666-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| XL184 | model; protects primary placental fibroblasts from Zika viru… | 1 mg | 18464-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| XL184 | model; protects primary placental fibroblasts from Zika viru… | 10 mg | 18464-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| XL184 | model; protects primary placental fibroblasts from Zika viru… | 5 mg | 18464-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| XL184 | model; protects primary placental fibroblasts from Zika viru… | 50 mg | 18464-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Human AB Serum (Heat Inactivated) | Ag, Anti-HCV, HTLV-1 / 2, Syphilis, Anti-HBc, Antibody screen, HIV-1 NAT,… | 100 ml, | abx810208 |
 ABBEXA LTD |
More Info |
| Human Whole Blood | Nile Virus NAT, Zika NAT and syphilis using FDA-approve… | 1 pack | ABC-TC4374 |
 ACCEGEN BIOTECH |
More Info |
| Emetine dihydrochloride | /beta-catenin signaling, and inhibits Zika and Ebola viruses<… | 50 mg, 250 mg, 1 g, 10 g | abx282851 |
ABBEXA LTD |
More Info |